Vasculitis & polymyalgia rheumatica

Incidence and prevalence of granulomatosis with polyangiitis in Sweden, 2006–2019, a register-based study

Semin Arthritis RheumPublished Register-based cohort study

Authors' conclusion

Our estimates show that incidence of GPA has been stable over the period 2006-2019 in Sweden which are in line with published data from southern Sweden.

Study context

Population
Entire Swedish population, 2006–2019; patients with incident and prevalent granulomatosis with polyangiitis (GPA) identified in the National Patient Registerincident GPA
Participants
2,013 participants
Outcome
Age- and sex-standardised annual incidence and crude period prevalence of GPA
Methodological detailsnationwide, population-based, National Patient Register
  • Nationwide
  • Population-based
  • National Patient Register

Main finding

As reported in the abstract

Mean standardised incidence of GPA · 2006–2019
Mean standardised incidence per 100,000 person-years
1.9 (95% CI 1.8-2.0)
Incidence in men per 100,000 person-years
2.0 (95% CI 1.9-2.2)
Incidence in women per 100,000 person-years
1.7 (95% CI 1.6-1.8)
Highest incidence, age 70-79, per 100,000 person-years (95% 3.7-4.5)
4.1
Annual incidence stable over the study period, range
1.7-2.0

Observational data: associations, not effects.

Further findings

Point prevalence of GPA · 31 December 2019

Point prevalence per 100,000 (95% CI 24.3-26.5); 2132 prevalent individuals
25.4

Period prevalence of GPA

2006-2010, per 100,000
18.7 (95% CI 17.8-19.1)
2016-2019, per 100,000
23.9 (95% CI 22.8-25.0)

Characteristics of incident GPA

Median age, years (IQR 51-72)
63
Women
46 %

Original publication

Incidence and prevalence of granulomatosis with polyangiitis in Sweden, 2006–2019, a register-based study. Semin Arthritis Rheum. Published 2 May 2025. doi:10.1016/j.semarthrit.2025.152745

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.